PTC three-lens brief
Evidence-based stock research on PTC. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 20.1pp over 30 days. · Trading at 7% of its 52-week range — deep in the lower band.
- Trading at 7% of its 52-week range — deep in the lower band.
- Underperforming SPY by 20.1pp over 30 days.
- Analyst mean target $186.21 — 36% above current (19 analysts).
- Debt-to-equity of 35.9 — balance-sheet-heavy.
PTC closed at $137.17 (+0.99%) as of 2026-04-25. Market cap: $16.32B. P/E (trailing) 20.2. Positives: analyst mean target $186.21 — 36% above current (19 analysts).. Concerns: trading at 7% of its 52-week range — deep in the lower band.; underperforming SPY by 20.1pp over 30 days.. Last quarter: Revenue $685.83M, net income $166.52M, free cash flow $786.88M.
Why three lenses on PTC, not one.
A single reasoning model has blind spots it doesn’t know about. We examine PTCacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/PTC" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath PTC brief"></iframe>